- Comparision of EGFR-TKI and chemotherapy in the first-line treatment …
Number of the records: 1  

Comparision of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC

  1. TitleComparision of EGFR-TKI and chemotherapy in the first-line treatment of advanced EGFR mutation-positive NSCLC / O. Fiala ... [et al.]
    Another responsib. Fiala, Ondřej (Author)
    Pešek, Miloš, 1950- (Author)
    Fínek, Jindřich, 1957- (Author)
    Mináriková, Lucie, 1974- (Author)
    Bortlíček, Zbyněk (Author)
    Minárik, Marek (Author)
    Translated titlePorovnanie EGFR-TKI a chemoterapie v prvolíniovej liečbe pokročilého NSCLC s pozitívnou mutáciou EGFR
    Phys.des.ilustr., grafy, tab.
    NoteBibliogr. odkazy. Res. angl.
    In Neoplasma. -- ISSN 0028-2685. -- Vol. 60, no. 4 (2013), s. 425-431
    Call numberC 720
    MeSH Subject karcinóm pľúc, nemalobunkový - farmakoterapia
    terapia molekulárne cielená
    inhibítory proteínkináz - použitie terapeutické - účinky nežiaduce
    receptory erbB - antagonisty a inhibítory - genetika
    mutácia
    výsledok liečby
    prežívanie
    Keywords erlotinib * gefitinib
    LanguageEnglish
    CountrySlovakia
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.